Fundz

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption

PUBLIC · DGXMay 01, 2024

Acquiring Company

Quest Diagnostics

Acquired Company

PathAI

SecaucusBostonData And AnalyticsHealth CareInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine LearningHealth Diagnostics

Description

Quest Diagnostics, a leader in diagnostic information services, has announced a multi-faceted collaboration with PathAI to accelerate the adoption of digital and AI pathology innovations, with the acquisition of select assets of PathAI Diagnostics. This collaboration aims to improve the quality, speed, and efficiency in diagnosing cancer and other diseases, leveraging Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations.

Quick answer

Quest Diagnostics is acquiring PathAI, announced May 1, 2024. Quest Diagnostics is based in Secaucus, New Jersey, United States.

How much did Quest Diagnostics pay for PathAI?
The deal value was not disclosed.
What does Quest Diagnostics do?
Quest Diagnostics empowers people to take action to improve health outcomes.
Where are Quest Diagnostics and PathAI based?
Quest Diagnostics is based in Secaucus, New Jersey, United States. PathAI is based in Boston, Massachusetts, United States.
Who are the decision-makers at Quest Diagnostics?
Fundz holds 2 contacts at Quest Diagnostics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Data And Analytics and Health Diagnostics

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Quest Diagnostics, and when

When Quest Diagnostics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Quest Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Quest Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Quest Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Quest Diagnostics

Location

500 Plaza Drive

Secaucus, New Jersey, United States

About

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com SOURCE Quest Diagnostics

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Quest Diagnostics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yuri
Likely contact at this company
••••••••@••••••••

See Yuri's verified email →

David
Likely contact at this company
••••••••@••••••••

See David's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Quest Diagnostics's next move

Learn about Strategic plan

Frequently asked

Who acquired PathAI?

PathAI was acquired by Quest Diagnostics, based in Secaucus. The deal was reported on May 1, 2024. Quest Diagnostics empowers people to take action to improve health outcomes. Quest Diagnostics is publicly traded (DGX) and operates in Data And Analytics.

When did Quest Diagnostics acquire PathAI?

Quest Diagnostics's acquisition of PathAI was reported on May 1, 2024. Quest Diagnostics, a leader in diagnostic information services, has announced a multi-faceted collaboration with PathAI to accelerate the adoption of digital and AI pathology innovations, with the acquisition of select assets of PathAI Diagnostics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PathAI do?

PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. It is privately held, operating in Information Technology, and is based in Boston.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.